IRCCS Azienda Ospedaliero-Universitaria di Bologna: Lymphoma trials
The registry lists 13 Lymphoma studies with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor. 9 are open to participants now and 0 have results posted.
No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study to Assess Effectiveness and Safety of Zanubrutinib for Patients with Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)RecruitingNCT06823960
- Italian Study of Patients with LymphomaRecruitingNCT06814925
- Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone LymphomasRecruitingNCT06806488
- An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under Named Patient ProgramRecruitingNCT06782789
- Study in Patients with Relapsed/refractory Primary Mediastinal Lymphoma Treated with Pembrolizumab or Nivolumab in Combination with Brentuximab Vedotin in a Real-life ContextRecruitingNCT06781450
- Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)RecruitingNCT06781437
- Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With AnthracyclinesRecruitingNCT06774326
- Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's LymphomaRecruitingNCT06761274Not applicable
- Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma.Not yet recruitingNCT06720701
- Microenvironmental Trial of Classical Hodgkin Lymphoma in AdolescentsCompletedNCT06814860
- Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid BiopsyCompletedNCT06782854
- An Italian Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated with Polatuzumab Vedotin Plus Rituximab (± Bendamustine) Under Named Patient ProgrammeActive, not recruitingNCT06734078
- Mediastinal Recurrence of Lympho-proliferative Disorders: a Biopsy is NeededCompletedNCT06714045